JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB176322

Anti-Loricrin antibody [EPR7148(2)(B)]

  • BOND RX™ Validated
  • 20ul selling size
  • Recombinant
  • Advanced Validation
  • RabMAb
  • What is this?

Be the first to review this product! Submit a review

|

(13 Publications)

Rabbit Recombinant Monoclonal Loricrin antibody. Suitable for mIHC, IHC-P, WB and reacts with Human samples. Cited in 13 publications.

View Alternative Names

LOR, LRN, LORICRIN, Loricrin

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)

Immunohistochemical analysis of paraffin-embedded Human skin tissue labeling Loricrin using ab176322 at a 1/250 dilution.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Multiplex immunohistochemistry - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)
  • mIHC

Supplier Data

Multiplex immunohistochemistry - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human skin tissue labelling Aquaporin 3 with ab307969 at 1/5000 dilution (0.094 µg/mL) (B), Loricrin with ab176322 at 1/3000 dilution (0.031 μg/ml) (C) and Filaggrin with ab221155 at 1/2000 dilution (0.523 μg/ml) (D). Opal Polymer HRP Ms + Rb was used as a secondary antibody, and DAPI was used for a nuclear counter stain. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins. Panel A : merged staining of anti-Aquaporin 3 (magenta; Opal™690), anti-Loricrin (green; Opal™520) and anti-Filaggrin (red; Opal™570) on human skin. Panel B : anti-Aquaporin 3 stained on keratinocytes from the stratum basale to the stratum granulosum of the epidermis. Panel C : anti-Loricrin stained on stratum corneum. Panel D : anti-Filaggrin stained on the granular to stratum corneum transition. The section was incubated in three rounds of staining : in the order of ab307969, ab176322, and ab221155 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

Western blot - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)
  • WB

Supplier Data

Western blot - Anti-Loricrin antibody [EPR7148(2)(B)] (AB176322)

All lanes:

Western blot - Anti-Loricrin antibody [EPR7148(2)(B)] (ab176322) at 1/10000 dilution

All lanes:

Human skin lysate at 10 µg

Predicted band size: 26 kDa

false

  • Carrier free

    Anti-Loricrin antibody [EPR7148(2)(B)] - BSA and Azide free

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Loricrin antibody [EPR7148(2)(B)]

  • 578 PE

    PE Anti-Loricrin antibody [EPR7148(2)(B)]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Loricrin antibody [EPR7148(2)(B)]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Loricrin antibody [EPR7148(2)(B)]

  • 660 APC

    APC Anti-Loricrin antibody [EPR7148(2)(B)]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Loricrin antibody [EPR7148(2)(B)]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-Loricrin antibody [EPR7148(2)(B)]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR7148(2)(B)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

mIHC, WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "mIHC" : {"fullname" : "Multiplex immunohistochemistry", "shortname":"mIHC"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "mIHC-species-checked": "testedAndGuaranteed", "mIHC-species-dilution-info": "1/3000", "mIHC-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/250 - 1/500", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Major keratinocyte cell envelope protein.
See full target information LORICRIN

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

Clinical, cosmetic and investigational dermatology 18:1151-1162 PubMed40356846

2025

-Derived Exosomes Enhance Skin Barrier Integrity by Upregulating Key Barrier-Related Proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Yong-Han Cho,Ji-Woo Kim,Nari Kim,Hee-Sik Kim,Jun-Hwan Jang,Jun-Tae Bae,Wanil Kim

Aging cell 24:e70024 PubMed40241256

2025

Targeting ATF6α Attenuates UVB-Induced Senescence and Improves Skin Homeostasis by Regulating IL8 Expression.

Applications

Unspecified application

Species

Unspecified reactive species

Joëlle Giroud,Pauline Delvaux,Laura Carlier,Clémentine De Schutter,Nathalie Martin,Raphaël Rouget,Ayeh Bolouki,Valérie De Glas,Inès Bouriez,Florent Bourdoux,Sophie Burteau,Julien Théry,Gauthier Decanter,Nicolas Penel,Yvan de Launoit,Benjamin Ledoux,Corinne Abbadie,Yves Poumay,Olivier Pluquet,Florence Debacq-Chainiaux

Journal of the European Academy of Dermatology and Venereology : JEADV 37:605-614 PubMed36367625

2022

An open source pipeline for quantitative immunohistochemistry image analysis of inflammatory skin disease using artificial intelligence.

Applications

Unspecified application

Species

Unspecified reactive species

Yuchun Ding,Gaurav Dhawan,Claire Jones,Thomas Ness,Esme Nichols,Natalio Krasnogor,Nick J Reynolds

International journal of molecular sciences 23: PubMed36361668

2022

An Inflamed and Infected Reconstructed Human Epidermis to Study Atopic Dermatitis and Skin Care Ingredients.

Applications

Unspecified application

Species

Unspecified reactive species

Sébastien Cadau,Manon Gault,Nicolas Berthelemy,Chiung-Yueh Hsu,Louis Danoux,Nicolas Pelletier,Dominique Goudounèche,Carole Pons,Corinne Leprince,Valérie André-Frei,Michel Simon,Sabine Pain

The Journal of investigative dermatology 142:1670-1681.e12 PubMed34740582

2021

Nicotinamide Prevents UVB- and Oxidative Stress‒Induced Photoaging in Human Primary Keratinocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Christina Yan Ru Tan,Chye Ling Tan,Toby Chin,Malgorzata Morenc,Chin Yee Ho,Holly A Rovito,Ling Shih Quek,Ai Ling Soon,John S Y Lim,Oliver Dreesen,John E Oblong,Sophie Bellanger

Inflammation 44:2006-2017 PubMed34037897

2021

Downregulation of Cathepsin B Reduces Proliferation and Inflammatory Response and Facilitates Differentiation in Human HaCaT Keratinocytes, Ameliorating IL-17A and SAA-Induced Psoriasis-Like Lesion.

Applications

Unspecified application

Species

Unspecified reactive species

Di Xu,Jie Wang

The Journal of investigative dermatology 141:2178-2188.e6 PubMed33984347

2021

The Polyamine Regulator AMD1 Upregulates Spermine Levels to Drive Epidermal Differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Anisa B Rahim,Hui Kheng Lim,Christina Yan Ru Tan,Li Jia,Vonny Ivon Leo,Takeshi Uemura,Jonathan Hardman-Smart,John E A Common,Thiam Chye Lim,Sophie Bellanger,Ralf Paus,Kazuei Igarashi,Henry Yang,Leah A Vardy

Scientific reports 11:7070 PubMed33782484

2021

In vitro skin culture media influence the viability and inflammatory response of primary macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Chiara Griffoni,Berna Neidhart,Ke Yang,Florian Groeber-Becker,Katharina Maniura-Weber,Thomas Dandekar,Heike Walles,Markus Rottmar

Experimental dermatology 30:792-803 PubMed33455013

2021

Increase in primary cilia in the epidermis of patients with atopic dermatitis and psoriasis.

Applications

Unspecified application

Species

Unspecified reactive species

Defri Rizaldy,Manami Toriyama,Hiroko Kato,Runa Fukui,Fumitaka Fujita,Motoki Nakamura,Fumihiro Okada,Akimichi Morita,Ken J Ishii

The Journal of investigative dermatology 140:1556-1565.e11 PubMed31987884

2020

WIF1 Suppresses the Generation of Suprabasal Cells in Acanthotic Skin and Growth of Basal Cell Carcinomas upon Forced Overexpression.

Applications

Unspecified application

Species

Unspecified reactive species

Marco Becker,Julia Bauer,Joanna Pyczek,Simone König,Anna Müllen,Hanna Rabe,Michael P Schön,Anja Uhmann,Heidi Hahn
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com